HBIO
Harvard Bioscience Inc
NASDAQ: HBIO · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$6.38
+4.08% today
Updated 2026-04-30
Market cap
$30.80M
P/E ratio
—
P/S ratio
0.36x
EPS (TTM)
$-12.80
Dividend yield
—
52W range
$3 – $9
Volume
0.2M
Harvard Bioscience Inc (HBIO) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
3 of 8
Last 8 quarters
Avg EPS surprise
—
Last 4 quarters
Revenue YoY growth
-3.3%
Most recent quarter
EPS YoY growth
-1163.8%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-5.9%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-7.7%
2025-11-06
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-05 | $-0.64 | -1695.8% | $0.57 | $0.55 | -4.1% |
| 2025-11-06 | $-0.03 | -400.0% | $0.59 | $0.54 | -7.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.04 | $-0.64 | -1695.8% | $23.73M | -3.3% |
| 2025-09-30 | $0.01 | $-0.03 | -400.0% | $20.59M | -6.3% |
| 2025-06-30 | $-0.01 | $-0.01 | -100.0% | $20.45M | -11.5% |
| 2025-03-31 | $-0.01 | $-0.01 | +0.0% | $21.77M | -11.2% |
| 2024-12-31 | $0.05 | $0.06 | +20.0% | $24.56M | -12.8% |
| 2024-09-30 | $0.03 | $-0.02 | -166.7% | $21.97M | -13.4% |
| 2024-06-30 | $0.05 | $-0.07 | -234.6% | $23.10M | -19.7% |
| 2024-03-31 | $0.02 | $0.02 | +0.0% | $24.51M | -18.2% |
| 2023-12-31 | $0.05 | $0.04 | -20.0% | $28.15M | — |
| 2023-09-30 | $0.04 | $0.01 | -75.0% | $25.36M | — |
| 2023-06-30 | $0.06 | $0.04 | -33.3% | $28.76M | — |
| 2023-03-31 | $0.05 | $0.06 | +20.0% | $29.98M | — |
Frequently asked questions
Has Harvard Bioscience Inc beaten earnings estimates?
Harvard Bioscience Inc has beaten Wall Street EPS estimates in 3 of its last 8 quarterly reports.
How does HBIO stock react to earnings?
HBIO stock has moved an average of -5.9% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.
What is Harvard Bioscience Inc's revenue growth rate?
Harvard Bioscience Inc reported year-over-year revenue growth of -3.3% in its most recent quarter, with EPS growing -1163.8% year-over-year.